Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_assertion type Assertion NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_head.
- NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_assertion description "[We have analysed, by in situ hybridization, mRNA expression of TGF-beta 1, TGF-beta 2, TGF-beta 3, and of TGF-beta type II receptor in benign melanocytic naevi, primary melanomas, and in skin metastases of malignant melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_provenance.
- NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_assertion evidence source_evidence_literature NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_provenance.
- NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_assertion SIO_000772 7614683 NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_provenance.
- NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_assertion wasDerivedFrom befree-20140225 NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_provenance.
- NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_assertion wasGeneratedBy ECO_0000203 NP431226.RAXq5S0vaRKibTLV7rIbeiDGfllBd0Hstoic3tZNai2zU130_provenance.